In summation, we were able to elucidate the role played by the ZEB1-DDX56-MIST1 axis in HCC, and our findings suggest that targeting the components of this axis may present a beneficial therapeutic approach for the treatment of HCC. Here, BHLHA15 is linked to hepatocellular carcinoma.